Colchicine Alternatives Compared
Colchicine | Ocaliva | Elafibranor |
|
---|
Colchicine | Ocaliva (obeticholic acid) | Elafibranor |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Colchicine is effective for preventing gout flares in adults; however, colchicine may interact with several other medications and cause gastrointestinal side effects at higher dosages. Prescribed for... View more |
Prescription only
Prescribed for Primary Biliary Cholangitis . Ocaliva may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Primary Biliary Cholangitis . elafibranor may also be used for purposes not listed in this medication guide. |
Related suggestions Primary Biliary Cholangitis
|
|||||||||||||||
More about Colchicine | More about Ocaliva (obeticholic acid) | More about Elafibranor | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Colchicine has an average rating of 7.3 out of 10 from a total of 99 ratings on Drugs.com. 65% of reviewers reported a positive effect, while 20% reported a negative effect. |
Ocaliva has an average rating of 7.0 out of 10 from a total of 2 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 0% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
See also: colchicine side effects in more detail. |
See also: Ocaliva side effects in more detail. |
See also: elafibranor side effects in more detail. |
||||||||||||||||
Generic Availability | ||||||||||||||||||
Lower cost generic |
N/A |
|||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all colchicine prices |
View all Ocaliva prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
Dosage Forms Available | ||||||||||||||||||
|
|
N/A |
||||||||||||||||
Brand Names | ||||||||||||||||||
Colcigel Gel, Colcrys, Gloperba, Lodoco, Mitigare |
N/A |
Iqirvo | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
1.5 hours |
N/A |
92.2 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 274 drugs are known to interact with colchicine:
|
A total of 63 drugs are known to interact with Ocaliva:
|
A total of 237 drugs are known to interact with elafibranor:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
July 29, 2009 |
May 27, 2016 |
June 10, 2024 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.